Physician

None

According to 2025 Medicare claims, NPI 1518905678 (NPI: 1518905678) practices hematology/oncology in the Helena, MT market, with the plurality of this provider's patient population coming from Lewis And Clark, MT. This provider's primary affiliated billing organization is BENEFIS HOSPITALS INC (NPI: 1780968974; TIN: 810232122) and primary practice location at 59601-3929. 1518905678 is affiliated with the Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

1518905678's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 112 traditional Medicare patients, billed 32,840 HCPCS/CPT codes, and received $589,809 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 374 prescription claims across 77 beneficiaries totaling $300,137 in drug costs, led by Exemestane (Exemestane). 2022 DME data shows 24 claims. Open Payments data shows 8 records totaling $351. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,213,866 and ending at $589,809. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $530,434 and ending at $300,137. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $11,363 to $1,123.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	471	152,625	$1,213,866
2016	60	8,145	$26,842
2017	342	36,814	$638,175
2018	442	75,421	$1,317,248
2019	229	69,308	$1,020,205
2020	231	85,438	$788,415
2021	429	94,605	$1,620,982
2022	195	29,750	$629,485
2023	90	147	$9,661
2024	112	32,840	$589,809

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	159	1,513	$530,434
2016	160	682	$833,211
2017	79	199	$60,312
2018	103	659	$1,227,216
2019	95	935	$2,572,449
2020	92	1,078	$2,218,962
2021	136	1,138	$2,788,513
2022	152	816	$1,448,089
2023	91	806	$1,106,904
2024	77	374	$300,137

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	212	$14,462
2016	N/R	24	$1,126
2017	N/R	42	$1,449
2018	N/R	28	$6,293
2019	N/R	66	$5,078
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	24	$1,677
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	47	47	$172
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	25	73	$130
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	51	155	$99
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	30	38	$71
36415	Insertion of needle into vein for collection of blood sample	25	65	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Exemestane	Exemestane	11	450	$782
Tamoxifen Citrate	Tamoxifen Citrate	22	960	$431
Prochlorperazine Maleate	Prochlorperazine Maleate	16	203	$244
Dexamethasone	Dexamethasone	13	146	$205
Ondansetron Hcl	Ondansetron Hcl	19	190	$123

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$351	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for NPI 1518905678?

Tedicare shows public-source Medicare data for NPI 1518905678 (NPI 1518905678), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does NPI 1518905678 have ACO affiliation data?

NPI 1518905678 is shown with ACO affiliation data for Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to NPI 1518905678?

NPI 1518905678 is linked to BENEFIS HOSPITALS INC (billing NPI 1780968974) in the available physician profile data.

Does NPI 1518905678 have Open Payments data?

NPI 1518905678 has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.